Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Recent publications published by researchers at the MRC WIMM.

The antigenic anatomy of SARS-CoV-2 receptor binding domain.

Dejnirattisai W. et al, (2021), Cell, 184, 2183 - 2200.e22

A haemagglutination test for rapid detection of antibodies to SARS-CoV-2.

Townsend A. et al, (2021), Nat Commun, 12

Hepcidin-Mediated Hypoferremia Disrupts Immune Responses to Vaccination and Infection.

Frost JN. et al, (2021), Med, 2, 164 - 179.e12

A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses.

Tan TK. et al, (2021), Nat Commun, 12

Lung-targeting lentiviral vector for passive immunisation against influenza

TAN TK. et al, (2020), Thorax

Vincenzo Cerundolo 1959-2020.

Townsend A., (2020), Nat Immunol, 21

Broadly Inhibiting Antineuraminidase Monoclonal Antibodies Induced by Trivalent Influenza Vaccine and H7N9 Infection in Humans.

Rijal P. et al, (2020), J Virol, 94

cGAMP loading enhances the immunogenicity of VLP vaccines

Chauveau L. et al, (2020)

Semaphorin 3A induces cytoskeletal paralysis in tumor-specific CD8+ T cells

Barnkob M. et al, (2019)

Broadly inhibiting anti-neuraminidase monoclonal antibodies induced by 1 trivalent influenza vaccine and H7N9 infection in humans

RIJAL P. and TOWNSEND A., (2019), Journal of Virology

Therapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated Humans.

Rijal P. et al, (2019), Cell Rep, 27, 172 - 186.e7

A single cycle influenza virus coated in H7 haemagglutinin generates neutralizing antibody responses to haemagglutinin and neuraminidase glycoproteins and protection from heterotypic challenge.

Powell TJ. et al, (2019), J Gen Virol, 100, 431 - 445

Structure-function analysis of neutralizing antibodies to H7N9 influenza from naturally infected humans.

Huang K-YA. et al, (2019), Nat Microbiol, 4, 306 - 315

Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection.

Saphire EO. et al, (2018), Cell, 174, 938 - 952.e13

Characterization of neutralizing epitopes in antigenic site B of recently circulating influenza A(H3N2) viruses.

Beer K. et al, (2018), J Gen Virol, 99, 1001 - 1011

Comparison of Heterosubtypic Protection in Ferrets and Pigs Induced by a Single-Cycle Influenza Vaccine.

Holzer B. et al, (2018), J Immunol, 200, 4068 - 4077

Structures of Ebola Virus Glycoprotein Complexes with Tricyclic Antidepressant and Antipsychotic Drugs.

Zhao Y. et al, (2018), J Med Chem, 61, 4938 - 4945

Induction of influenza-specific local CD8 T-cells in the respiratory tract after aerosol delivery of vaccine antigen or virus in the Babraham inbred pig.

Tungatt K. et al, (2018), PLoS Pathog, 14

Characterization of Influenza Virus Pseudotyped with Ebolavirus Glycoprotein.

Xiao JH. et al, (2018), J Virol, 92

Lack of Truncated IFITM3 Transcripts in Cells Homozygous for the rs12252-C Variant That is Associated With Severe Influenza Infection.

Makvandi-Nejad S. et al, (2018), J Infect Dis, 217, 257 - 262

Load More

1
2
3
4
5
6

Include forthcoming?